Director, Finance Gross-to-Net Reporting - Job ID : DFGR

Ascendis Pharma is a dynamic, fast-growing global biopharmaceutical company with locations in Denmark, Europe, and the United States. Today, we're advancing programs in Endocrinology Rare Disease and Oncology.

Here at Ascendis, we pride ourselves on exceptional science, visionary leadership, and skilled and passionate colleagues.

Guided by our core values of Patients, Science, and Passion, we use our TransCon drug development platform to fulfill our mission of developing new and potentially best-in-class therapies to address unmet medical needs.

Our culture fosters a place where skilled, adaptable, and highly resourceful professionals can truly make their mark. We offer a dynamic workplace for employees to grow and develop their skills.

Position Summary

The Director, Finance Gross-to-Net (GTN) Reporting will lead the development, execution, and oversight of government pricing and GTN analytics & Reporting across the U.S. business. This individual will serve as a strategic partner to Finance, Market Access, Analytics & Commercial Operations and other US teams, ensuring compliance with evolving federal and state pricing regulations while maximizing net revenue and supporting business planning and decision-making. This role requires a deep understanding of U.S. government pricing programs, GTN forecasting and analytics, and the pharmaceutical reimbursement landscape.

Key Responsibilities

• Lead the GTN efforts, including modeling, forecasting, accruals, and scenario planning to inform financial planning and product pricing decisions.
• Partner cross-functionally with Market Access, Trade, Patient Support Services, Analytics & Commercial Operations, other US Commercial teams, Global Finance, and Legal teams to inform GTN forecast, assess and optimize pricing strategies, and net revenue performance.
• Guide the design and enhancement of automation tools and dashboards to streamline data aggregation, analytics, and executive reporting for GTN and government pricing.
• Serve as a key contributor in the implementation of new legislation (e.g., Inflation Reduction Act), including development of pricing strategies, modeling, and policy impact assessments.
• Lead the end-to-end government pricing reporting and operations, including oversight of calculations, compliance, and reporting for programs such as AMP, BP, PHS, FSS / VA, ASP, nFAMP, FCP, IFF, and URA.
• Oversee the development and maintenance of SOPs, assumptions documentation, and procedural controls to ensure audit readiness and policy alignment.
• Manage reviews and approvals of monthly accruals, reconciliations, utilization files (e.g., rebates, 340B claims, disputes), and reporting packages to ensure accuracy and compliance.
• Stay abreast of industry trends, policy changes, and regulatory updates; evaluate their potential impact on GTN, pricing strategy, and financial forecasts.
• Serve as the primary point of contact for internal and external audits related to government pricing or GTN.
• Champion cross-functional initiatives related to FMV analysis, bona fide service fees, state transparency reporting, and other pricing-related special projects.

Knowledge, Skills and Experience

Salary Range : $190,000 - $225,000 / year Depending on Experience

A note to recruiters :

We do not allow external search party solicitation. Presentation of candidates without written permission from the Ascendis Pharma Inc Human Resources team (specifically from : Talent Acquisition Partner or Human Resources Director) is not allowed. If this occurs your ownership of these candidates will not be acknowledged.

#J-18808-Ljbffr